MyoPAXon
- Generic Name
- MyoPAXon
Trial of Cell Based Therapy for DMD
- First Posted Date
- 2024-11-18
- Last Posted Date
- 2025-03-24
- Lead Sponsor
- Masonic Cancer Center, University of Minnesota
- Target Recruit Count
- 8
- Registration Number
- NCT06692426
- Locations
- 🇺🇸
Masonic Cancer Center, Minneapolis, Minnesota, United States
Drug Development Updates
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.
© Copyright 2025. All Rights Reserved by MedPath